National Consortium
The Clinical and Translational Science Awards (CTSA) is a registered trademark of DHHS.
Working together as a national consortium, CTSA institutions share a common vision to improve human health by transforming the research and training environment to enhance the efficiency and quality of Clinical and Translational Research.
The Clinical and Translational Science Awards (CTSAs) program creates a definable academic home for clinical and translational research. CTSA institutions work to transform the local, regional, and national environment to increase the efficiency and speed of clinical and translational research across the country.
The CTSA program is led by the National Center for Advancing Translational Sciences part of the National Institutes of Health. Drawing from experience of the NIH Office of Strategic Coordination – The Common Fund and extensive community input.
Currently, more than 50 medical research institutions in 31 states and the District of Columbia receive Clinical and Translational Science Awards (CTSA) Program funding. These institutions are working together to speed the translation of research discovery into improved patient care. The CTSA consortium is funded by the National Center for Advancing Translational Sciences (NCATS), a part of the National Institutes of Health (NIH).
Working Together, Sharing a Vision The CTSA consortium aims to improve human health by transforming the research and training environment to enhance the efficiency and quality of clinical and translational research. The CTSA consortium has five Strategic Goals to:
- Train and cultivate the translational science workforce;
- Engage patients and communities in every phase of the translational process;
- Promote the integration of special and underserved populations in translational research across the human lifespan;
- Innovate processes to increase the quality and efficiency of translational research, particularly of multisite trials; and
- Advance the use of cutting-edge informatics.
